Upgrade and get full access to Xvivo Perfusion.
Gain complete access to Xvivo Perfusion’s insights, verified by our analysts’ to keep you informed.
Why is this company behind paywall?
Upcoming Earnings Report
Earnings Date
18 Feb, 2025
In 30 Days
Revenue Estimate
105.76 M
15.8% (YoY)
EBITDA Estimate
-14.21 M
-47.6% (YoY)
EBIT Estimate
-55.21 M
-17.8% (YoY)
EPS Estimate
-1.48
-23.6% (YoY)
Upgrade and get full access to Xvivo Perfusion.
Gain complete access to Xvivo Perfusion’s insights, verified by our analysts’ to keep you informed.
Why is this company behind paywall?
Historical Estimates
Quarterly
Annual
REV
EBITDA
EBIT
EPS
Current Estimates
Quarterly
Annual
No data available
Analyst Stats
Jacob Benon
Lead Analyst
JB
Shareholder
Analyst Transactions
Historical Surprises
Quarterly EBIT
Estimates
Actual
Met
| Name | EBIT Surprise | 3-Day Alpha | Report Date |
|---|---|---|---|
| Precise Biometrics | -36.85% | -25.55% | 2024-08-16 |
Earnings from similar companies
Analyst Stats
No data available
Historical Surprises
Quarterly EBIT
Estimates
Actual
Met
| Name | EBIT Surprise | 3-Day Alpha | Report Date |
|---|---|---|---|
| Precise Biometrics | -36.85% | -25.55% | 2024-08-16 |
Earnings from similar companies